Cargando…
Classification of triple negative breast cancer by epithelial mesenchymal transition and the tumor immune microenvironment
Triple-negative breast cancer (TNBC) accounts for about 15–20% of all breast cancers and differs from other invasive breast cancer types because it grows and spreads rapidly, it has limited treatment options and typically worse prognosis. Since TNBC does not express estrogen or progesterone receptor...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187759/ https://www.ncbi.nlm.nih.gov/pubmed/35688895 http://dx.doi.org/10.1038/s41598-022-13428-2 |